NCT00750620View on ClinicalTrials.gov

A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment

PHASE1CompletedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Renal Impairment

Interventions

DRUG

YM178

oral

Trial Locations (2)

92801

Anaheim

33014-3616

Miami

Sponsors

Lead Sponsor

Astellas Pharma Inc

All Listed Sponsors

lead

Astellas Pharma Inc

INDUSTRY